Curcumin, an active component of turmeric in the prevention and treatment of ulcerative colitis: Preclinical and clinical observations

Food and Function

Volumn 3, Issue 11, 2012, Pages 1109-1117

  Baliga, Manjeshwar Shrinath ^a   Joseph, Nandhini ^a   Venkataranganna, Marikunte V ^b   Saxena, Arpit ^c   Ponemone, Venkatesh ^d   Fayad, Raja ^c  

^a FATHER MULLER MEDICAL COLLEGE   (India)

^b Connexios Life Sciences Pvt Ltd ^*  (India)

^c UNIVERSITY OF SOUTH CAROLINA   (United States)

^d Center for Cellular Medicine   (India)

Author keywords

[No Author keywords available]

Indexed keywords

FOOD PRODUCTS; FREE RADICALS; TRANSCRIPTION FACTORS;

ACTIVE COMPONENTS; ACTIVE PRINCIPLES; ACTIVITY INDEX; CLINICAL INVESTIGATION; CLINICAL OBSERVATION; CLINICAL STUDY; CONVENTIONAL DRUGS; CROHN'S DISEASE; CURCUMA LONGA; CURCUMIN; EXPERIMENTAL ANIMALS; EXPERIMENTAL MODELS; IMMUNOMODULATORS; INFLAMMATORY BOWEL DISEASE; INHIBITORY EFFECT; LARGE BOWEL; MYELOPEROXIDASE; PRECLINICAL STUDIES; SIDE EFFECT; SIGNALING PATHWAYS; ULCERATIVE COLITIS;

DISEASES;

ANIMALIA; CURCUMA LONGA;

ANTIOXIDANT; CURCUMIN; CYTOKINE; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INDUCIBLE NITRIC OXIDE SYNTHASE; PEROXIDASE; PROSTAGLANDIN SYNTHASE INHIBITOR; PROTEIN KINASE; SCAVENGER;

ANIMAL; CHEMISTRY; CURCUMA; DRUG ANTAGONISM; DRUG EFFECT; HUMAN; INDIA; METABOLISM; REVIEW; SIGNAL TRANSDUCTION; TRADITIONAL MEDICINE; ULCERATIVE COLITIS;

ANIMALS; ANTIOXIDANTS; COLITIS, ULCERATIVE; CURCUMA; CURCUMIN; CYCLOOXYGENASE INHIBITORS; CYTOKINES; FREE RADICAL SCAVENGERS; HUMANS; INDIA; MEDICINE, TRADITIONAL; NF-KAPPA B; NITRIC OXIDE SYNTHASE TYPE II; PEROXIDASE; PROTEIN KINASES; SIGNAL TRANSDUCTION;

EID: 84868684156     PISSN: 20426496     EISSN: 2042650X     Source Type: Journal    
DOI: 10.1039/c2fo30097d     Document Type: Review

References (54)

1. P. L. Kozuch S. B. Hanauer Treatment of inflammatory bowel disease: a review of medical therapy World J. Gastroenterol. 2008 14 354 377 (Pubitemid 351320845)
2. A. G. Jagtap S. S. Shirke A. S. Phadke Effect of polyherbal formulation on experimental models of inflammatory bowel diseases J. Ethnopharmacol. 2004 90 195 204 (Pubitemid 38180477)
3. I. Chattopadhyay K. Biswas U. Bandyopadhyay R. K. Banerjee Turmeric and curcumin: biological actions and medicinal applications Curr. Sci. 2004 87 44 53 (Pubitemid 39403908)
4. H. Hatcher R. Planalp J. Cho F. M. Torti S. V. Torti Curcumin: from ancient medicine to current clinical trials Cell. Mol. Life Sci. 2008 65 1631 1652
5. M. Schaffer P. M. Schaffer J. Zidan G. Bar-Sela Curcuma as a functional food in the control of cancer and inflammation Curr. Opin. Clin. Nutr. Metab. Care 2011 14 588 597
6. R. A. Taylor M. C. Leonard Curcumin for inflammatory bowel disease: a review of human studies Altern. Med. Rev. 2011 16 152 156
7. A. Shehzad T. Ha F. Subhan Y. S. Lee New mechanisms and the anti-inflammatory role of curcumin in obesity and obesity-related metabolic diseases Eur. J. Nutr. 2011 50 151 161
8. R. F. Tayyem D. D. Heath W. K. Al-Delaimy C. L. Rock Curcumin content of turmeric and curry powders Nutr. Cancer 2006 55 126 131 (Pubitemid 44719625)
9. T. Ali F. Shakir J. Morton Curcumin and inflammatory bowel disease: biological mechanisms and clinical implication Digestion 2012 85 249 255
10. K. Sugimoto H. Hanai K. Tozawa T. Aoshi M. Uchijima T. Nagata Y. Koide Curcumin prevents and ameliorates trinitrobenzene sulfonic acid-induced colitis in mice Gastroenterology 2002 123 1912 1922 (Pubitemid 35408315)
11. B. Salh K. Assi V. Templeman K. Parhar D. Owen A. Gómez- Muñoz K. Jacobson Curcumin attenuates DNB-induced murine colitis Am. J. Physiol.: Gastrointest. Liver Physiol. 2003 285 G235 43
12. A. Ukil S. Maity S. Karmakar N. Datta J. R. Vedasiromoni P. K. Das Curcumin, the major component of food flavour turmeric, reduces mucosal injury in trinitrobenzene sulphonic acid-induced colitis Br. J. Pharmacol. 2003 139 209 18 (Pubitemid 36760353)
13. Y. T. Jian J. D. Wang G. F. Mai Y. L. Zhang Z. S. Lai Modulation of intestinal mucosal inflammatory factors by curcumin in rats with colitis Di Yi Jun Yi Da Xue Xue Bao 2004 24 1353 1358
14. Y. T. Jian G. F. Mai J. D. Wang Y. L. Zhang R. C. Luo Y. X. Fang Preventive and therapeutic effects of NF-kappaB inhibitor curcumin in rats colitis induced by trinitrobenzene sulfonic acid World J. Gastroenterol. 2005 11 1747 1752
15. M. Zhang C. Deng J. Zheng J. Xia D. Sheng Curcumin inhibits trinitrobenzene sulphonic acid-induced colitis in rats by activation of peroxisome proliferator-activated receptor gamma Int. Immunopharmacol. 2006 6 1233 1242 (Pubitemid 43868183)
16. M. Zhang C. S. Deng J. J. Zheng J. Xia Curcumin regulated shift from Th1 to Th2 in trinitrobenzene sulphonic acid-induced chronic colitis Acta Pharmacol. Sin. 2006 27 1071 1077 (Pubitemid 44127918)
17. J. K. Uno O. I. Kolek E. R. Hines H. Xu B. N. Timmermann P. R. Kiela F. K. Ghishan The role of tumor necrosis factor alpha in down-regulation of osteoblast Phex gene expression in experimental murine colitis Gastroenterology 2006 131 497 509 (Pubitemid 44142455)
18. Y. Deguchi A. Andoh O. Inatomi Y. Yagi S. Bamba Y. Araki K. Hata T. Tsujikawa Y. Fujiyama Curcumin prevents the development of dextran sulfate sodium (DSS)-induced experimental colitis Dig. Dis. Sci. 2007 52 2993 2998 (Pubitemid 47512496)
19. L. Martelli E. Ragazzi F. di Mario M. Martelli I. Castagliuolo M. Dal Maschio G. Palù M. Maschietto M. Scorzeto S. Vassanelli P. Brun A potential role for the vanilloid receptor TRPV1 in the therapeutic effect of curcumin in dinitrobenzene sulphonic acid-induced colitis in mice Neurogastroenterol. Motil. 2007 19 668 674 (Pubitemid 47084123)
20. L. Camacho-Barquero I. Villegas J. M. Sánchez-Calvo E. Talero S. Sánchez-Fidalgo V. Motilva C. Alarcón de la Lastra Curcumin, a Curcuma longa constituent, acts on MAPK p38 pathway modulating COX-2 and iNOS expression in chronic experimental colitis Int. Immunopharmacol. 2007 7 333 342 (Pubitemid 46186172)
21. M. V. Venkataranganna M. Rafiq S. Gopumadhavan G. Peer U. V. Babu S. K. Mitra NCB-02 (standardized curcumin preparation) protects dinitrochlorobenzene- induced colitis through down-regulation of NFkB and iNOS World J. Gastroenterol. 2007 13 1103 1107 (Pubitemid 46511014)
22. C. Billerey-Larmonier J. K. Uno N. Larmonier A. J. Midura B. Timmermann F. K. Ghishan P. R. Kiela Protective effects of dietary curcumin in mouse model of chemically induced colitis are strain dependent Inflammatory Bowel Dis. 2008 14 780 793 (Pubitemid 351898063)
23. A. Lubbad M. A. Oriowo I. Khan Curcumin attenuates inflammation through inhibition of TLR-4 receptor in experimental colitis Mol. Cell. Biochem. 2009 322 127 135
24. H. M. Arafa R. A. Hemeida A. I. El-Bahrawy F. M. Hamada Prophylactic role of curcumin in dextran sulfate sodium (DSS)-induced ulcerative colitis murine model Food Chem. Toxicol. 2009 47 1311 1317
25. S. Mouzaoui I. Rahim B. Djerdjouri Aminoguanidine and curcumin attenuated tumor necrosis factor (TNF)-α-induced oxidative stress, colitis and hepatotoxicity in mice Int. Immunopharmacol. 2012 12 302 311
26. M. T. Midura-Kiela V. M. Radhakrishnan C. B. Larmonier D. Laubitz F. K. Ghishan P. R. Kiela Curcumin inhibits interferon-γ signaling in colonic epithelial cells Am. J. Physiol.: Gastrointest. Liver Physiol. 2012 302 1 G85 G96
27. C. B. Larmonier J. K. Uno K. M. Lee T. Karrasch D. Laubitz R. Thurston M. T. Midura-Kiela F. K. Ghishan R. B. Sartor C. Jobin P. R. Kiela Limited effects of dietary Curcumin on Th1 driven colitis in IL-10 deficient mice suggest an IL-10-dependent mechanism of protection Am. J. Physiol.: Gastrointest. Liver Physiol. 2008 295 G1079 G1091
28. K. Nones Y. E. Dommels S. Martell C. Butts W. C. McNabb Z. A. Park S. Zhu D. Hedderley M. P. Barnett N. C. Roy The effects of dietary curcumin and rutin on colonic inflammation and gene expression in multidrug resistance gene-deficient (mdr1a -/-) mice, a model of inflammatory bowel diseases Br. J. Nutr. 2009 101 169 181
29. H. Jiang C. S. Deng M. Zhang J. Xia Curcumin-attenuated trinitrobenzene sulphonic acid induces chronic colitis by inhibiting expression of cyclooxygenase-2 World J. Gastroenterol. 2006 12 3848 3853 (Pubitemid 44028396)
30. M. Fukata M. T. Abreu TLR4 signalling in the intestine in health and disease Biochem. Soc. Trans. 2007 35 1473 1478
31. K. Katayama K. Wada A. Nakajima H. Mizuguchi T. Hayakawa S. Nakagawa T. Kadowaki R. Nagai Y. Kamisaki R. S. Blumberg T. Mayumi A novel PPAR gamma gene therapy to control inflammation associated with inflammatory bowel disease in a murine model Gastroenterology 2003 124 1315 1324 (Pubitemid 36531806)
32. Y. M. Shah K. Morimura F. J. Gonzalez Expression of peroxisome proliferator-activated receptor-gamma in macrophage suppresses experimentally induced colitis Am. J. Physiol.: Gastrointest. Liver Physiol. 2007 292 G657 G666
33. P. Basnet N. Skalko-Basnet Curcumin: an anti-inflammatory molecule from a curry spice on the path to cancer treatment Molecules 2011 16 4567 4598
34. P. K. Roy F. Rashid J. Bragg J. A. Ibdah Role of the JNK signal transduction pathway in inflammatory bowel disease World J. Gastroenterol. 2008 14 200 202 (Pubitemid 351314299)
35. O. J. Broom B. Widjaya J. Troelsen J. Olsen O. H. Nielsen Mitogen activated protein kinases: a role in inflammatory bowel disease? Clin. Exp. Immunol. 2009 158 272 280
36. J. Epstein G. Docena T. T. MacDonald I. R. Sanderson Curcumin suppresses p38 mitogen-activated protein kinase activation, reduces IL-1b and matrix metalloproteinase-3 and enhances IL-10 in the mucosa of children and adults with inflammatory bowel disease Br. J. Nutr. 2010 103 824 832
37. B. B. Aggarwal S. Shishodia Y. Takada D. Jackson-Bernitsas K. S. Ahn G. Sethi H. Ichikawa TNF blockade: an inflammatory issue Ernst Schering Res. Found. Workshop 2006 56 161 186
38. C. Jobin C. A. Bradham M. P. Russo B. Juma A. S. Narula D. A. Brenner R. B. Sartor, Curcumin blocks cytokine-mediated NF-kappa B activation and pro-inflammatory gene expression by inhibiting inhibitory factor I-kappa B kinase activity J. Immunol. 1999 163 3474 3483 (Pubitemid 29431852)
39. F. Sanchez-Munoz A. Dominguez-Lopez J. K. Yamamoto-Furusho Role of cytokines in inflammatory bowel disease World J. Gastroenterol. 2008 14 4280 4288
40. L. Hai Y. Kawarabayashi Y. Imai A. Honda R. Inoue Counteracting effect of TRPC1-associated Ca2+ influx on TNF-α-induced COX-2-dependent prostaglandin E2 production in human colonic myofibroblasts Am. J. Physiol.: Gastrointest. Liver Physiol. 2011 301 G356 G367
41. Q. Wang X. L. Guo D. Wells-Byrum G. Noel T. A. Pritts C. K. Ogle Cytokine-induced epithelial permeability changes are regulated by the activation of the p38 mitogen-activated protein kinase pathway in cultured Caco-2 cells Shock 2008 29 531 537 (Pubitemid 351416808)
42. T. Y. Ma G. K. Iwamoto N. T. Hoa V. Akotia A. Pedram M. A. Boivin H. M. Said TNF-α-induced increase in intestinal epithelial tight junction permeability requires NF-kappa B activation Am. J. Physiol.: Gastrointest. Liver Physiol. 2004 286 G367 G376
43. R. M. Al-Sadi T. Y. Ma IL-1beta causes an increase in intestinal epithelial tight junction permeability J. Immunol 2007 178 4641 4649 (Pubitemid 46492417)
44. L. Lih-Brody S. R. Powell K. P. Collier G. M. Reddy R. Cerchia E. Kahn G. S. Weissman S. Katz R. A. Floyd M. J. McKinley S. E. Fisher G. E. Mullin Increased oxidative stress and decreased antioxidant defenses in mucosa of inflammatory bowel disease Dig. Dis. Sci. 1996 41 2078 2086 (Pubitemid 26366811)
45. R. K. Cross K. T. Wilson Nitric oxide in inflammatory bowel disease Inflammatory Bowel Dis. 2003 9 179 189 (Pubitemid 36592449)
46. M. N. Sreejayan, Rao. Curcuminoids as potent inhibitors of lipid peroxidation J. Pharm. Pharmacol. 1994 46 1013 1016
47. M. Onoda H. Inano Effect of curcumin on the production of nitric oxide by cultured rat mammary gland Nitric Oxide 2000 4 505 515
48. L. Maggio-Price D. Shows K. Waggie A. Burich W. Zeng S. Escobar P. Morrissey J. L. Viney Helicobacter bilis infection accelerates and H. hepaticus infection delays the development of colitis in multiple drug resistance-deficient (mdr1a -/-) mice Am. J. Pathol. 2002 160 739 751 (Pubitemid 34160352)
49. C. M. Panwala J. C. Jones J. L. Viney A novel model of inflammatory bowel disease: mice deficient for the multiple drug resistance gene, mdr1a, spontaneously develop colitis J. Immunol. 1998 161 5733 5744 (Pubitemid 28519142)
50. J. N. Wilk J. Bilsborough J. L. Viney The mdr1a -/- mouse model of spontaneous colitis: a relevant and appropriate animal model to study inflammatory bowel disease Immunol. Res. 2005 31 151 159 (Pubitemid 40631385)
51. P. R. Holt S. Katz R. Kirshoff Curcumin therapy in inflammatory bowel disease: a pilot study Dig. Dis. Sci. 2005 50 2191 2193 (Pubitemid 41504112)
52. H. Hanai T. Iida K. Takeuchi F. Watanabe Y. Maruyama A. Andoh T. Tsujikawa Y. Fujiyama K. Mitsuyama M. Sata M. Yamada Y. Iwaoka K. Kanke H. Hiraishi K. Hirayama H. Arai S. Yoshii M. Uchijima T. Nagata Y. Koide Curcumin maintenance therapy for ulcerative colitis: randomized, multicenter, double-blind, placebo-controlled trial Clin. Gastroenterol. Hepatol. 2006 4 1502 1506 (Pubitemid 44880023)
53. H. Hanai K. Sugimoto Curcumin has bright prospects for the treatment of inflammatory bowel disease Curr. Pharm. Des. 2009 15 2087 2094
54. V. Jančinová T. Perečko R. Nosáĺ D. Mihalová K. Bauerová K. Drábiková Pharmacological regulation of neutrophil activity and apoptosis Contribution to new strategy for modulation of inflammatory processes Interdiscip. Toxicol. 2011 4 11 14